ArticleThe Lancet. Global health2024

Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.

Byron W P Reeve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.